CRISPR Therapeutics AG - Company Profile
Powered by 
All the sales intelligence you need on CRISPR Therapeutics AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CRISPR Therapeutics AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CRISPR Therapeutics AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
CRISPR Therapeutics AG (CRISPR) is a gene editing company. The company’s improved operational performance, focus on research and development activities, and proprietary technology enable it to improve its gene-editing platform. Decline in revenue is a cause for concern for the company. Strategic agreements and regulatory approvals can lead to the growth of the company. However, intense competition, healthcare reforms in the US and stringent regulations could affect the business of the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer